Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Visit

EHA 2023 | Looking forward to the Cancer Genomics Consortium Annual Meeting

Rashmi Kanagal-Shamanna • 7 Jun 2023

EHA 2023

Leukemia

Rashmi Kanagal-Shamanna, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, shares her enthusiasm for the upcoming Cancer Genomics Consortium (CGC) annual meeting in St Louis, Missouri on 13-16th August 2023. The event will host speakers and symposia regarding the use of state-of-the-art genomics for clinical care, diagnostics, prognostics, and therapy decisions and is currently open for registration. This interview took place at the 28th Congress of the European Hematology Association (EHA) 2023 in Frankfurt, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Common germline mutations in myelodysplastic syndromes

Rashmi Kanagal-Shamanna • 7 Jun 2023

Incidence of germline mutations in patients with myeloid neoplasms with antecedent solid tumors

Rashmi Kanagal-Shamanna • 7 Jun 2023

Automated tool for MDS classification using the WHO & ICC classification systems

Rashmi Kanagal-Shamanna • 5 May 2023

Clinical utility of the homologous recombination deficiency score in AML & MDS

Rashmi Kanagal-Shamanna • 11 Dec 2022

Related Videos

The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial

Felicitas Thol • 19 Apr 2024

Integrating genomics and MRD in transplant decision-making for patients with AML

Jurjen Versluis • 22 Apr 2024

Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL

Alberto Olaya-Vargas • 15 Apr 2024

Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS

Sridhar Chaganti • 16 Apr 2024